Full Text View
Tabular View
No Study Results Posted
Related Studies
MK0991 Versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients
This study has been completed.
Study NCT00082537   Information provided by Merck
First Received: May 11, 2004   Last Updated: May 13, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Neutropenia
Fever
More general conditions related to this trial
Agranulocytosis
Body Temperature Changes
Hematologic Diseases
Leukocyte Disorders
Leukopenia
Signs and Symptoms
Interventions listed in this trial
caspofungin acetate
Comparator: AmBisome
Additional drug interventions recognized in this trial
Abelcet
Amphotericin B
Caspofungin
Liposomal amphotericin B
More general drug interventions related to this trial
Amebicides
Anti-Bacterial Agents
Anti-Infective Agents
Antibiotics, Antifungal
Antifungal Agents
Antiparasitic Agents
Antiprotozoal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Merck


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services